Fiercebiotech
Published November 16, 2026 · Updated November 17, 2026
Biogen inks $411M neurodegeneration pact with protein degrader biotech TrimTech
Read the full story at Fiercebiotech
The company, a 2025 inductee into Fierce Biotech's Fierce ... Helus' chemically modified psychedelic hits key goals in phase 3 depression trial.
Surfaced by this Google Alert
- Psychedelic biotech